# Dual-attention ResNet outperforms transformers in HER2 prediction on DCE-MRI

arXiv: https://arxiv.org/abs/2510.13897 · HTML: https://mlsanity.com/paper/2510.13897/

## Key facts

- No citing papers in the map yet (data through 14 Oct 2026).
- Builds on 7 of its 53 references that are in the map.
- First posted on arXiv 14 Oct 2025.

## Builds on (most cited first, 7 of 7)

- [An Image is Worth 16x16 Words: Transformers for Image Recognition at Scale](https://mlsanity.com/paper/2010.11929/) (2020)
- [Delving Deep into Rectifiers: Surpassing Human-Level Performance on ImageNet Classification](https://mlsanity.com/paper/1502.01852/) (2015)
- [CvT: Introducing Convolutions to Vision Transformers](https://mlsanity.com/paper/2103.15808/) (2021)
- [Residual Attention Network for Image Classification](https://mlsanity.com/paper/1704.06904/) (2017)
- [Breast Cancer Classification with Enhanced Interpretability: DALAResNet50 and DT Grad-CAM](https://mlsanity.com/paper/2308.13150/) (2023)
- [BreastDCEDL: A Comprehensive Breast Cancer DCE-MRI Dataset and Transformer Implementation for Treatment Response Prediction](https://mlsanity.com/paper/2506.12190/) (2025)
- [Transformer Classification of Breast Lesions: The BreastDCEDL_AMBL Benchmark Dataset and 0.92 AUC Baseline](https://mlsanity.com/paper/2509.26440/) (2025)

## Abstract (arXiv)

Breast cancer is the most diagnosed cancer in women, with HER2 status critically guiding treatment decisions. Noninvasive prediction of HER2 status from dynamic contrast-enhanced MRI (DCE-MRI) could streamline diagnostics and reduce reliance on biopsy. However, preprocessing high-dynamic-range DCE-MRI into standardized 8-bit RGB format for pretrained neural networks is nontrivial, and normalization strategy significantly affects model performance. We benchmarked intensity normalization strategies using a Triple-Head Dual-Attention ResNet that processes RGB-fused temporal sequences from three DCE phases. Trained on a multicenter cohort (n=1,149) from the I-SPY trials and externally validated on BreastDCEDL_AMBL (n=43 lesions), our model outperformed transformer-based architectures, achieving 0.75 accuracy and 0.74 AUC on I-SPY test data. N4 bias field correction slightly degraded performance. Without fine-tuning, external validation yielded 0.66 AUC, demonstrating cross-institutional generalizability. These findings highlight the effectiveness of dual-attention mechanisms in capturing transferable spatiotemporal features for HER2 stratification, advancing reproducible deep learning biomarkers in breast cancer imaging.
